Gene Therapy Clinical Trials
Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer
This pilot clinical trial studies imaging during surgery in diagnosing patients with prostate, bladder, or kidney cancer. New diagnostic imaging procedures, may find prostate, bladder, or kidney cancer
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- procedure: photoacoustic imaging
- procedure: fluorescence imaging
- procedure: robot-assisted laparoscopic surgery
Eligibility
Inclusion Criteria:
- Patients must have a pathologic confirmation of prostate cancer, bladder cancer, or
kidney cancer based on previous biopsies or procedures OR a strong concern for a
kidney malignancy based on computed tomography (CT) or magnetic resonance imaging
(MRI) imaging
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- Patients with a surgical history or anatomic variant that would preclude robot
assisted laparoscopic approaches to their surgery (i.e. history of ventral hernia
repair with mesh)
- Patients with medical co-morbidities who cannot tolerate laparoscopic surgery
secondary to intra-abdominal carbon dioxide insufflation
- Patients with documented allergy or adverse drug reaction to indocyanine green or
baseline serum creatinine greater than 1.5 mg/dL
Ages Eligible for Study
18 Years - 85 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Mark Gonzalgo
650-725-5544
Not Recruiting